Close Menu

proteomics

Proteomics

The companies will evaluate the performance of Proteomics International's PromarkerD test for predicting decline in kidney function and drug response.

Founded last year, the company plans to develop mass spec-based tests to protein isoforms using a workflow that eliminates both LC and protein digestion.

Freenome will leverage proteomics firm Biognosys' technology to add protein quantification to the development of Freenome's first commercially available screening test.

Merlin will become Bruker's Center of Excellence for specialty and selected antibiotic-resistance and -susceptibility testing. 

NEW YORK (GenomeWeb) – Astute Medical said this week that it has received US Food and Drug Administration 510(k) clearance for its NephroCheck Test System, a protein biomarker-based test for assessing risk of acute kidney injury.

This story has been updated with comments from outside researchers and clinicians. LC-MS-based proteomics has officially entered the clinic with the launch this week of Integrated Diagnostics' Xpresys Lung test.

Point-of-care device manufacturer Abaxis and biosensor firm LamdaGen said this week that they have entered into an R&D agreement aiming to integrate LamdaGen's plasmonic ELISA technology on Abaxis's rotor-based POC platforms.